Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  Allemagne

CME Congresses

We are happy to announce the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), Hybrid Congress which will take place October 27-30, 2022 in Berlin, Germany, and online. We are planning to hold the congress as a hybrid edition (with both face-to-face and virtual components). COSTEM is moving to become an annual event as we feel it is important to build a platform for our community to interact with each other and to share our scientific research, clinical experience, and on-going developments in our field. COSTEM encourages active participation in debate discussions, and challenges global experts to promote their positions on a wide range of burning issues – providing clinicians the opportunity to share, express and compare experiences to establish and advance effective and reliable patient treatments. The 7th COSTEM Congress will continue to push the envelope and be a progressive, compelling, and informative conference. As in the past, COSTEM continues to serve as a unique platform, where the most compelling and controversial topics facing clinicians in these fields are presented in a fascinating and exciting debate forum.

Email.: costem@cme-congresses.com

• CAR-T cell therapy • Haploidentical stem cell transplantation • Cellular therapy • Transplantation • GVHD prevention and treatment • Cord blood transplantation • Mesenchymal stem cell • Acute leukemia • Myelodysplastic syndrome • Multiple myeloma • Hodgkin and Non-Hodgkin lymphoma • Myeloproliferative neoplasm • Virus specific T Cell therapy • NK Cell therapy • Microbiome • Genome editing and gene therapy • Bone marrow failure syndrome • Bi-specific antibodies • CMV infection • Toxicity post transplantation (VOD, TMA etc)

Hématologie,    Formation médicale continue (FMC)

European Association For Cancer Research (ECAR)

The EACR conference on "Cellular bases for patient response to conventional cancer therapies" will highlight the latest cutting-edge advances in the understanding of molecular pathways involved in cancer response to therapy. The scientific programme blends basic and translational research, including data from patient responses and from research performed in mouse models.

Deutsche Krebsgesellschaft e. V. (www.krebsgesellschaft.de) und Stiftung Deutsche Krebshilfe (www.krebshilfe.de)

Erfolge in der Krebstherapie hängen auch von der Qualität der einzelnen Schnittstellen ab. Ein schneller Transfer – gesicherter medizinischer Innovationen von Forschung in die Versorgung - ist eine wichtige Voraussetzung für den onkologischen Fortschritt. Die Schnittstelle und Zusammenarbeit aus verschiedenen ärztlichen Fächern und Gesundheitsberufen sowie Patient*innen ist ebenfalls sehr bedeutsam.

Deutsche Krebsgesellschaft e. V. - Frau Janina Henne;     Tél.: [+49 30 3229329-21];     Email.: dkk2022@krebsgesellschaft.de

Tumormedizin, Krebsforschung, Krebserkrankungen, Tumorarten, Hilfe/Selbsthilfe, Psychoonkologie, Palliativmedizin, Kommunikation, Gesundheitspolitik

Hématologie,    Médecine (en général), médecine interne

Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments in immune oncology. This year’s focus will be on tumor microenvironment, cell-based therapy in hematology and oncology, precision medicine addressing tolerance and inflammation, immune checkpoint inhibitors, biomarkers, and cancer vaccines. You are invited to submit an abstract of your scientific work to be presented virtually as a poster at LION 2022. We are looking forward to welcoming you virtually at the Leipzig Immune ONcology (LION) Conference on November 22-23, 2022.

Fraunhofer Institute for Cell Therapy and Immunology;     Tél.: [+49 341 35536-9320];     Email.: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Hématologie,    Immunologie et Allergie

Precision Medicine Forum

This two-day forum brings together experts from across Europe and beyond to provide a truly unique environment for meaningful interactions with those at the very forefront of precision oncology. The multidisciplinary agenda will provide a platform for healthcare professionals, industry, patients groups, research, payers and Government to share their experiences and vision for a future of improved patient outcomes.

Email.: amber@precisionmedicineforum.com

Topics will include: Developments with molecular analysis, Addressing inequality, diversity and inclusivity in care, access and treatment, Data harmonisation and interoperability, Profiling the future patient, Clinical implementation of precision oncology, Latest developments in liquid biopsy, and much more...

Deutsche Krebsgesellschaft Berlin, Deutsche Krebshilfe

The AEK Cancer Congress hosts around 500 participants. It is funded by the German Cancer Society and the German Cancer Aid and will be held in 2023 under the theme “Towards New Cancer Therapies: Mechanisms and Molecules”. You will see that we have assembled a great line-up of outstanding speakers, who will cover multiple exciting topics of current biology, from basic mechanism to new immunotherapies and the development of new therapeutic molecules.

Tél.: [+49 364324680];     Email.: katharina.pracht@kukm.de

Cancer, oncology, internal medicine, AEK, hematology

Deutsche Gesellschaft für Radioonkologie e. V.

Auf dem Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO) haben alle Fachkollegen/innen der DEGRO Gelegenheit, alle für die Entwicklung der Radioonkologie wichtigen Aspekte in konzentrierter Form zu diskutieren und: so zu einem breiten Erkenntnisaustausch zu kommen. Herausragende Forschungsleistungen werden auf diesem Kongress durch Wissenschaftspreise ausgezeichnet. An diesem Kongress sind auch die Angehörigen der in der Radioonkologie tätigen weiteren Berufsgruppen der MTRA (VMTRO), der Pflegenden in der Radioonkologie (BVPRO), der Medizinischen Fachangestellten in der Radioonkologie (MFAaBRO) und der Officeberufe (OVIRO) aktiv beteiligt.

Die Programmschwerpunkte des DEGRO-Kongress 2023 sind: Neue Technologien – neue Dosiskonzepte | High Tech – High Care: Der Patient im Mittelpunkt | Digitalisierung und Artificial Intelligence | Radio-Immuntherapie, Radio-Chemotherapie or what? | Arbeit im multiprofessionellen Team.

Kongressorganisation;     Tél.: [+49 3643 2468-0];     Email.: degro@kukm.de

Radioonkologie, Onkologie, Radiotherapie, Medizinphysik, Strahlenbiologie, Radioimmuntherapie, Radiochemotherapie, Digitalisierung, AI, Patientenzentrierung

Radiologie, médecine nucléaire et radiothérapie,    Médecine translationnelle, essais cliniques

Conventus Congressmanagement & Marketing GmbH

Email.: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email.: conferencemarketing@conventus.de